Exact Mass: 490.2427374
Exact Mass Matches: 490.2427374
Found 439 metabolites which its exact mass value is equals to given mass value 490.2427374,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rubraflavone C
Rubraflavone C is found in fruits. Rubraflavone C is a constituent of Morus rubra (red mulberry)
PA(2:0/18:2(10E,12Z)+=O(9))
C23H39O9P (490.23315740000004)
PA(2:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:2(10E,12Z)+=O(9)/2:0)
C23H39O9P (490.23315740000004)
PA(18:2(10E,12Z)+=O(9)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/2:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/18:2(9Z,11E)+=O(13))
C23H39O9P (490.23315740000004)
PA(2:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:2(9Z,11E)+=O(13)/2:0)
C23H39O9P (490.23315740000004)
PA(18:2(9Z,11E)+=O(13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/2:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/18:3(10,12,15)-OH(9))
C23H39O9P (490.23315740000004)
PA(2:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:3(10,12,15)-OH(9)/2:0)
C23H39O9P (490.23315740000004)
PA(18:3(10,12,15)-OH(9)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/2:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/18:3(9,11,15)-OH(13))
C23H39O9P (490.23315740000004)
PA(2:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:3(9,11,15)-OH(13)/2:0)
C23H39O9P (490.23315740000004)
PA(18:3(9,11,15)-OH(13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/2:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Tanariflavanone B
A trihydroxyflavanone that consists of (2S)-2,3-dihydro-2H,4H-2,5-bichromen-4-one skeleton substituted by hydroxy groups at positions 5, 7 and 8, a methyl group at position 2, a prenyl group at position 6 and a 4-methylpent-3-enyl group at position 2. Isolated from Macaranga tanarius, it exhibits alleopathic effect.
dorsilurin E
Moralbanone
Artocommunol CD
Artelasticin
Dorsilurin A
Rubraflavone C
DORSILURIN F
A 7-hydroxyflavonol substituted by additional hydroxy groups at positions 5 and 3 and prenyl groups at positions 6, 8 and 4. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity. D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D004791 - Enzyme Inhibitors
DORSILURIN K
An extended flavonoid that is flavonol with an additional hydroxy group at position 3, two 2,2-dimethyldihydropyrano rings fused to ring A across positions 5, 6 and 7, 8 respectively and a prenyl group at position 4. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity.
(+)-angelicoidenol 2-O-[6-O-S-3-hydroxy-3-methylglutaryl]-beta-D-glucopyranoside|zingiberoside C methyl ester
C23H38O11 (490.24139979999995)
DORSILURIN J
An extended flavonoid that is 7-hydroxyflavonol with an additional hydroxy group at position 3, a 2,2-dimethyldihydropyrano ring fused to ring A across positions 5 and 6, and prenyl groups at positions 8 and 4. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity.
1-[5,7-dihydroxy-2-methyl-6-(3-methylbut-2-enyl)-2-(4-methylpent-3-enyl)chromen-8-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one
(+)-7,7-bis[(5R,7R,9R,10S)-2-oxocadinan-3,6(11)-dien-12,7-olide]
5,7,2,4-tetrahydroxy-3-geranyl-8-prenylflavone|artocommunol CD
(2S)-5,2,4-trihydroxy-8,5-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone
3-(3,4-dihydroxyphenyl)-1-[6-(3,7-dimethylocta-2,6-dienyl)-5,7-dihydroxy-2,2-dimethylchromen-8-yl]prop-2-en-1-one
8-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one|moralbanone
5,7,3-trihydroxy-4,5-(2,2-dimethylpyran)-8,2-di(3-methyl-2-butenyl)-(2S)-flavanone
An extended flavonoid that consists of (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 3, prenyl groups at positions 8 and 2 and a gem-dimethyl pyran ring fused across positions 4 and 5. Isolated from Dendrolobium lanceolatum, it exhibits antimalarial activity.
Thr Asp Gln Lys
C19H34N6O9 (490.23871540000005)
Ser Glu Gln Lys
C19H34N6O9 (490.23871540000005)
Lys Gln Ser Glu
C19H34N6O9 (490.23871540000005)
Asp Gln Thr Lys
C19H34N6O9 (490.23871540000005)
Thr Asn Lys Glu
C19H34N6O9 (490.23871540000005)
Thr Lys Asn Glu
C19H34N6O9 (490.23871540000005)
Asn Thr Glu Lys
C19H34N6O9 (490.23871540000005)
3-Geranyl-3-prenyl-5,7,2,4-tetrahydroxyflavone
Cys Gly Arg Arg
C17H34N10O5S (490.24342340000004)
Cys Arg Gly Arg
C17H34N10O5S (490.24342340000004)
Cys Arg Arg Gly
C17H34N10O5S (490.24342340000004)
Asp Phe Ile Pro
Asp Phe Leu Pro
Asp Phe Pro Ile
Asp Phe Pro Leu
Asp Ile Phe Pro
Asp Ile Ile Met
Asp Ile Leu Met
Asp Ile Met Ile
Asp Ile Met Leu
Asp Ile Pro Phe
Asp Lys Gln Thr
C19H34N6O9 (490.23871540000005)
Asp Lys Thr Gln
C19H34N6O9 (490.23871540000005)
Asp Leu Phe Pro
Asp Leu Ile Met
Asp Leu Leu Met
Asp Leu Met Ile
Asp Leu Met Leu
Asp Leu Pro Phe
Asp Met Ile Ile
Asp Met Ile Leu
Asp Met Leu Ile
Asp Met Leu Leu
Asp Pro Phe Ile
Asp Pro Phe Leu
Asp Pro Ile Phe
Asp Pro Leu Phe
Asp Gln Lys Thr
C19H34N6O9 (490.23871540000005)
Asp Thr Lys Gln
C19H34N6O9 (490.23871540000005)
Asp Thr Gln Lys
C19H34N6O9 (490.23871540000005)
Glu Phe Pro Val
Glu Phe Val Pro
Glu Ile Met Val
Glu Ile Val Met
Glu Lys Asn Thr
C19H34N6O9 (490.23871540000005)
Glu Lys Gln Ser
C19H34N6O9 (490.23871540000005)
Glu Lys Ser Gln
C19H34N6O9 (490.23871540000005)
Glu Lys Thr Asn
C19H34N6O9 (490.23871540000005)
Glu Leu Met Val
Glu Leu Val Met
Glu Met Ile Val
Glu Met Leu Val
Glu Met Val Ile
Glu Met Val Leu
Glu Asn Lys Thr
C19H34N6O9 (490.23871540000005)
Glu Asn Thr Lys
C19H34N6O9 (490.23871540000005)
Glu Pro Phe Val
Glu Pro Val Phe
Glu Gln Lys Ser
C19H34N6O9 (490.23871540000005)
Glu Gln Ser Lys
C19H34N6O9 (490.23871540000005)
Glu Ser Lys Gln
C19H34N6O9 (490.23871540000005)
Glu Ser Gln Lys
C19H34N6O9 (490.23871540000005)
Glu Thr Lys Asn
C19H34N6O9 (490.23871540000005)
Glu Thr Asn Lys
C19H34N6O9 (490.23871540000005)
Glu Val Phe Pro
Glu Val Ile Met
Glu Val Leu Met
Glu Val Met Ile
Glu Val Met Leu
Glu Val Pro Phe
Phe Asp Ile Pro
Phe Asp Leu Pro
Phe Asp Pro Ile
Phe Asp Pro Leu
Phe Glu Pro Val
Phe Glu Val Pro
Phe Ile Asp Pro
Phe Ile Pro Asp
Phe Leu Asp Pro
Phe Leu Pro Asp
Phe Pro Asp Ile
Phe Pro Asp Leu
Phe Pro Glu Val
Phe Pro Ile Asp
Phe Pro Leu Asp
Phe Pro Val Glu
Phe Val Glu Pro
Phe Val Pro Glu
Gly Cys Arg Arg
C17H34N10O5S (490.24342340000004)
Gly Arg Cys Arg
C17H34N10O5S (490.24342340000004)
Gly Arg Arg Cys
C17H34N10O5S (490.24342340000004)
Ile Asp Phe Pro
Ile Asp Ile Met
Ile Asp Leu Met
Ile Asp Met Ile
Ile Asp Met Leu
Ile Asp Pro Phe
Ile Glu Met Val
Ile Glu Val Met
Ile Phe Asp Pro
Ile Phe Pro Asp
Ile Ile Asp Met
Ile Ile Met Asp
Ile Leu Asp Met
Ile Leu Met Asp
Ile Met Asp Ile
Ile Met Asp Leu
Ile Met Glu Val
Ile Met Ile Asp
Ile Met Leu Asp
Ile Met Val Glu
Ile Pro Asp Phe
Ile Pro Phe Asp
Ile Val Glu Met
Ile Val Met Glu
Lys Asp Gln Thr
C19H34N6O9 (490.23871540000005)
Lys Asp Thr Gln
C19H34N6O9 (490.23871540000005)
Lys Glu Asn Thr
C19H34N6O9 (490.23871540000005)
Lys Glu Gln Ser
C19H34N6O9 (490.23871540000005)
Lys Glu Ser Gln
C19H34N6O9 (490.23871540000005)
Lys Glu Thr Asn
C19H34N6O9 (490.23871540000005)
Lys Asn Glu Thr
C19H34N6O9 (490.23871540000005)
Lys Asn Thr Glu
C19H34N6O9 (490.23871540000005)
Lys Gln Asp Thr
C19H34N6O9 (490.23871540000005)
Lys Gln Glu Ser
C19H34N6O9 (490.23871540000005)
Lys Gln Thr Asp
C19H34N6O9 (490.23871540000005)
Lys Ser Glu Gln
C19H34N6O9 (490.23871540000005)
Lys Ser Gln Glu
C19H34N6O9 (490.23871540000005)
Lys Thr Asp Gln
C19H34N6O9 (490.23871540000005)
Lys Thr Glu Asn
C19H34N6O9 (490.23871540000005)
Lys Thr Asn Glu
C19H34N6O9 (490.23871540000005)
Lys Thr Gln Asp
C19H34N6O9 (490.23871540000005)
Leu Asp Phe Pro
Leu Asp Ile Met
Leu Asp Leu Met
Leu Asp Met Ile
Leu Asp Met Leu
Leu Asp Pro Phe
Leu Glu Met Val
Leu Glu Val Met
Leu Phe Asp Pro
Leu Phe Pro Asp
Leu Ile Asp Met
Leu Ile Met Asp
Leu Leu Asp Met
Leu Leu Met Asp
Leu Met Asp Ile
Leu Met Asp Leu
Leu Met Glu Val
Leu Met Ile Asp
Leu Met Leu Asp
Leu Met Val Glu
Leu Pro Asp Phe
Leu Pro Phe Asp
Leu Val Glu Met
Leu Val Met Glu
Met Asp Ile Ile
Met Asp Ile Leu
Met Asp Leu Ile
Met Asp Leu Leu
Met Glu Ile Val
Met Glu Leu Val
Met Glu Val Ile
Met Glu Val Leu
Met Ile Asp Ile
Met Ile Asp Leu
Met Ile Glu Val
Met Ile Ile Asp
Met Ile Leu Asp
Met Ile Val Glu
Met Leu Asp Ile
Met Leu Asp Leu
Met Leu Glu Val
Met Leu Ile Asp
Met Leu Leu Asp
Met Leu Val Glu
Met Val Glu Ile
Met Val Glu Leu
Met Val Ile Glu
Met Val Leu Glu
Asn Glu Lys Thr
C19H34N6O9 (490.23871540000005)
Asn Glu Thr Lys
C19H34N6O9 (490.23871540000005)
Asn Lys Glu Thr
C19H34N6O9 (490.23871540000005)
Asn Lys Thr Glu
C19H34N6O9 (490.23871540000005)
Asn Arg Thr Thr
Asn Thr Lys Glu
C19H34N6O9 (490.23871540000005)
Asn Thr Arg Thr
Asn Thr Thr Arg
Pro Asp Phe Ile
Pro Asp Phe Leu
Pro Asp Ile Phe
Pro Asp Leu Phe
Pro Glu Phe Val
Pro Glu Val Phe
Pro Phe Asp Ile
Pro Phe Asp Leu
Pro Phe Glu Val
Pro Phe Ile Asp
Pro Phe Leu Asp
Pro Phe Val Glu
Pro Ile Asp Phe
Pro Ile Phe Asp
Pro Leu Asp Phe
Pro Leu Phe Asp
Pro Val Glu Phe
Pro Val Phe Glu
Gln Asp Lys Thr
C19H34N6O9 (490.23871540000005)
Gln Asp Thr Lys
C19H34N6O9 (490.23871540000005)
Gln Glu Lys Ser
C19H34N6O9 (490.23871540000005)
Gln Glu Ser Lys
C19H34N6O9 (490.23871540000005)
Gln Lys Asp Thr
C19H34N6O9 (490.23871540000005)
Gln Lys Glu Ser
C19H34N6O9 (490.23871540000005)
Gln Lys Ser Glu
C19H34N6O9 (490.23871540000005)
Gln Lys Thr Asp
C19H34N6O9 (490.23871540000005)
Gln Arg Ser Thr
Gln Arg Thr Ser
Gln Ser Glu Lys
C19H34N6O9 (490.23871540000005)
Gln Ser Lys Glu
C19H34N6O9 (490.23871540000005)
Gln Ser Arg Thr
Gln Ser Thr Arg
Gln Thr Asp Lys
C19H34N6O9 (490.23871540000005)
Gln Thr Lys Asp
C19H34N6O9 (490.23871540000005)
Gln Thr Arg Ser
Gln Thr Ser Arg
Arg Cys Gly Arg
C17H34N10O5S (490.24342340000004)
Arg Cys Arg Gly
C17H34N10O5S (490.24342340000004)
Arg Gly Cys Arg
C17H34N10O5S (490.24342340000004)
Arg Gly Arg Cys
C17H34N10O5S (490.24342340000004)
Arg Asn Thr Thr
Arg Gln Ser Thr
Arg Gln Thr Ser
Arg Arg Cys Gly
C17H34N10O5S (490.24342340000004)
Arg Arg Gly Cys
C17H34N10O5S (490.24342340000004)
Arg Ser Gln Thr
Arg Ser Thr Gln
Arg Thr Asn Thr
Arg Thr Gln Ser
Arg Thr Ser Gln
Arg Thr Thr Asn
Ser Glu Lys Gln
C19H34N6O9 (490.23871540000005)
Ser Lys Glu Gln
C19H34N6O9 (490.23871540000005)
Ser Lys Gln Glu
C19H34N6O9 (490.23871540000005)
Ser Gln Glu Lys
C19H34N6O9 (490.23871540000005)
Ser Gln Lys Glu
C19H34N6O9 (490.23871540000005)
Ser Gln Arg Thr
Ser Gln Thr Arg
Ser Arg Gln Thr
Ser Arg Thr Gln
Ser Thr Gln Arg
Ser Thr Arg Gln
Thr Asp Lys Gln
C19H34N6O9 (490.23871540000005)
Thr Glu Lys Asn
C19H34N6O9 (490.23871540000005)
Thr Glu Asn Lys
C19H34N6O9 (490.23871540000005)
Thr Lys Asp Gln
C19H34N6O9 (490.23871540000005)
Thr Lys Glu Asn
C19H34N6O9 (490.23871540000005)
Thr Lys Gln Asp
C19H34N6O9 (490.23871540000005)
Thr Asn Glu Lys
C19H34N6O9 (490.23871540000005)
Thr Asn Arg Thr
Thr Asn Thr Arg
Thr Gln Asp Lys
C19H34N6O9 (490.23871540000005)
Thr Gln Lys Asp
C19H34N6O9 (490.23871540000005)
Thr Gln Arg Ser
Thr Gln Ser Arg
Thr Arg Asn Thr
Thr Arg Gln Ser
Thr Arg Ser Gln
Thr Arg Thr Asn
Thr Ser Gln Arg
Thr Ser Arg Gln
Thr Thr Asn Arg
Thr Thr Arg Asn
Val Glu Phe Pro
Val Glu Ile Met
Val Glu Leu Met
Val Glu Met Ile
Val Glu Met Leu
Val Glu Pro Phe
Val Phe Glu Pro
Val Phe Pro Glu
Val Ile Glu Met
Val Ile Met Glu
Val Leu Glu Met
Val Leu Met Glu
Val Met Glu Ile
Val Met Glu Leu
Val Met Ile Glu
Val Met Leu Glu
Val Pro Glu Phe
Val Pro Phe Glu
3,5,6-tri-O-.benzyl-1,2-O-isopropylidene-alpha-D-glucofuranose
[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(Diphenylamino)carbonyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbamic acid ethyl ester
C29H34N2O5 (490.24675940000003)
[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
C23H39O9P (490.23315740000004)
[(2R)-2-acetyloxy-3-phosphonooxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
C23H39O9P (490.23315740000004)
[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
C23H39O9P (490.23315740000004)
[(2R)-2-acetyloxy-3-phosphonooxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
C23H39O9P (490.23315740000004)
rac-(2E)-1-[5,7-dihydroxy-2-methyl-6-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)-2H-chromen-8-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one
Mallotophilippen D
A member of the class of chalcones that is chalcone substituted by hydroxy groups at positions 3, 4, 2 and 4, a geranyl group at position 3 and a 6,6-dimethyl-3,6-dihydro-2H-pyran ring fused across positions 5 and 6. Isolated from the fruits of Mallotus philippensis, it exhibits anti-inflammatory and immunoregulatory activities.
1-(2,5-difluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H32F2N4O4 (490.23914959999996)
(3S,6aR,8S,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
1-(2,5-difluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H32F2N4O4 (490.23914959999996)
(3S,6aS,8R,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3R,6aR,8R,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3R,6aS,8R,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3S,6aR,8R,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3R,6aS,8S,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
2-cyclopropyl-N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
2-cyclopropyl-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
2-cyclopropyl-N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclobutanecarboxamide
1-(2,5-difluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H32F2N4O4 (490.23914959999996)
2-cyclopropyl-N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
2-cyclopropyl-N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
2-cyclopropyl-N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
2-cyclopropyl-N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
2-cyclopropyl-N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-cyclopropyl-N-methylacetamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclobutanecarboxamide
1-(2,5-difluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H32F2N4O4 (490.23914959999996)
1-(2,5-difluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H32F2N4O4 (490.23914959999996)
1-(2,5-difluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H32F2N4O4 (490.23914959999996)
(3R,6aR,8S,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3S,6aS,8S,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(RS)-mallotophilippen E
A racemate composed of equimolar quantities of R- and S- mallotophilippen E. Isolated from the fruits of Mallotus philippensis, it exhibits anti-inflammatory and immunoregulatory activities.
mallotophilippen E
A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 3, 4, 2 and 4, a prenyl group at position 3 and a 6-methyl-6-(4-methylpent-3-en-1-yl)-3,6-dihydro-2H-pyran ring fused across positions 5 and 6
5,7-dihydroxy-2-[8-hydroxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)chromen-6-yl]-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
13,26-dihydroxy-1,6,6,20,24-pentamethyl-7,22-dioxahexacyclo[13.12.0.0²,¹³.0⁵,¹¹.0¹⁶,²⁵.0¹⁸,²³]heptacosa-9,11,16(25),17,19,23-hexaene-8,21-dione
(2s)-5,7-dihydroxy-2-[(2s)-8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
5,7-dihydroxy-2-[8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
5,7-dihydroxy-2-[8-hydroxy-2-methyl-2-(4-methylpenta-1,3-dien-1-yl)-3,4-dihydro-1-benzopyran-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2r)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone
{"Ingredient_id": "HBIN006516","Ingredient_name": "(2r)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone","Alias": "NA","Ingredient_formula": "C30H34O6","Ingredient_Smile": "CC(=CCC1=C(C=C(C(=C1)C2CC(=O)C3=C(C4=C(C(=C3O2)CC=C(C)C)OC(C=C4)(C)C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21701","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone
{"Ingredient_id": "HBIN006751","Ingredient_name": "(2s)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone","Alias": "NA","Ingredient_formula": "C30H34O6","Ingredient_Smile": "CC(=CCC1=C(C=C(C(=C1)C2CC(=O)C3=C(C4=C(C(=C3O2)CC=C(C)C)OC(C=C4)(C)C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21702","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}